Kyntra Bio, Inc. (0IL8.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Kyntra Bio, Inc.
Address
350 Bay Street
San Francisco, CA 94133
United States of America (the)
Phone
415 978 1200
Website
Sector
Healthcare
Industry
Biotechnology
Employees
34
First IPO Date
January 29, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Thane Wettig | Chief Executive Officer & Director | 1.27M | 1965 |
| David DeLucia | Senior Vice President & Chief Financial Officer | 769,345 | 1989 |
| Carrie Brownstein | Chief Medical Officer | 0 | 1970 |
| Carol Gaddum | Vice President of Product Development | 0 | N/A |
| Michelle Simonetti | Head of People and Culture & Executive Director | 0 | N/A |
| Gaia Vasiliver-Shamis | Director of IR & Communications - LifeSci Advisors | 0 | N/A |
| John Alden | Corporate Secretary & General Counsel | 0 | N/A |
AD
Description
Kyntra Bio, Inc. is a biopharmaceutical enterprise focused on the entire spectrum of therapeutic innovation, from discovering new compounds to developing and commercializing them. Leveraging profound insights into hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology, the company strives to engineer effective medicinal solutions for anemia, fibrotic conditions, and various forms of cancer. Founded by Thomas B. Neff on September 29, 1993, Kyntra Bio, Inc. maintains its corporate headquarters in San Francisco, California.
AD
